Q2 saw resilient margins and stable EBITDA despite a 1% organic sales decline, with growth excluding last year's IPR settlement. Rising input costs and challenging macro conditions are being addressed through price increases, product redesign, and cost actions. AI adoption and new IPR agreements position the company for future growth.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.